Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone for pain control in patients with COVID-19
IRCT20150107020592N24Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of oxycodone in coronavirus disease 2019 (COVID-19), sponsored by Shahid Beheshti University of Medical Sciences. Started Mar 2020; status: completed.
02
Drugs
oxycodone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20150107020592N24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150107020592N24.